Although no target residual plasma levels are defined in the context of F/P + chronic eosinophilic leukemia, undetectable drug plasma levels can avoid unnecessary sequencing of PDGFRA. The gene discussed is PDGFRA; the disease is Chronic Eosinophilic Leukemia, Not Otherwise Specified.